{"id":13279,"date":"2025-04-07T16:53:00","date_gmt":"2025-04-07T16:53:00","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/?post_type=webinar-and-podcast&#038;p=13279"},"modified":"2026-01-23T17:11:03","modified_gmt":"2026-01-23T17:11:03","slug":"linker-technologies-in-adcs-how-they-impact-efficacy-and-stability","status":"publish","type":"webinar-and-podcast","link":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/","title":{"rendered":"Linker Technologies in ADCs: How They Impact Efficacy and Stability"},"content":{"rendered":"\n<p>In Part 3, the discussion moves to linkers\u2014often overlooked but fundamental to ADC behaviour. The episode covers linker stability, controlled release, and how thoughtful linker design can enhance both efficacy and therapeutic windows.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-2-xl-font-size\" style=\"padding-top:var(--wp--preset--spacing--40)\">About the Authors<\/h3>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-123a282d wp-block-columns-is-layout-flex\" style=\"padding-bottom:var(--wp--preset--spacing--40)\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"593\" src=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/sygnature-adc-expert-interview-studio.webp\" alt=\"Picture of Allan Jordan, VP of Oncology Drug Discovery at Sygnature Discovery and Joshua Greally, ADC Lead and Business Development Associate for Drug Discovery Services at Sygnature Discovery, filming the podcast style video series: ADC Development for Sygnature's NewPath ADC series\" class=\"wp-image-13275\" srcset=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/sygnature-adc-expert-interview-studio.webp 800w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/sygnature-adc-expert-interview-studio-300x222.webp 300w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/sygnature-adc-expert-interview-studio-768x569.webp 768w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/sygnature-adc-expert-interview-studio-486x360.webp 486w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/sygnature-adc-expert-interview-studio-640x474.webp 640w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p style=\"padding-left:var(--wp--preset--spacing--40)\">Allan Jordan is Vice President Oncology Drug Discovery at Sygnature Discovery and Josh Greally is ADC Lead at Sygnature Discovery.<\/p>\n<\/div>\n<\/div>\n\n\n<section class=\"Pegasus__Container w-full   relative h-fit  text-content-dark mobile-stacking-standard is-layout-flow wp-block-pegasus-container-is-layout-flow\" style=\"   \" >\n\t        \n\t\n\t\t\t\t\t\t\n\t\t        \t\t\n\t\t\t\t\t\t\t\n\t\t\t<div class=\"inner relative h-full is-flex-layout flex flex-col justify-start  w-full\">\n<section x-data=\"PegasusMediaBlock\" \n         class=\"Media object-contain w-full layout h-full\"\n         style=\"\">\n            \n                            \n\n            <div class=\"w-full h-0 relative \" style=\"padding-bottom: 56.25%\">\n            <iframe title=\"ADC Development Series Ep3: Linker Technologies in ADCs - How They Impact Efficacy &amp; Stability\" src=\"https:\/\/www.youtube.com\/embed\/dKc1CcQ_Ayw?feature=oembed&amp;rel=0&amp;autoplay=&amp;mute=&amp;muted=&amp;loop=&amp;controls=0\" width=\"640\" height=\"360\" loading=\"eager\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" class=\"video-embed w-full h-full absolute-center \" controls=\"0\"  frameborder=\"0\"><\/iframe>\n        <\/div>\n    \n    <div x-ref=\"videoPlaceholder\" class=\"absolute-center w-full !h-full\" @click=\"playVideo()\">\n        \n\n        <div class=\"preview-play-button absolute-center w-full h-full cursor-pointer\" title=\"Play Full Video\" @click=\"videoModalOpen = true\">\n            <button type=\"button\" class=\"absolute absolute-center w-16 h-16 bg-white\/80 rounded-full flex items-center justify-center\">\n                <span class=\"sr-only\">Play Full Video<\/span>\n                <svg width=\"17\" height=\"20\" viewBox=\"0 0 17 20\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path d=\"M16.5 8.79609C17.1667 9.18099 17.1667 10.1432 16.5 10.5281L1.5 19.1884C0.833335 19.5733 9.70611e-07 19.0922 1.00426e-06 18.3224L1.76136e-06 1.00185C1.79501e-06 0.232054 0.833336 -0.24907 1.5 0.13583L16.5 8.79609Z\" fill=\"#002B46\"\/>\n                <\/svg>\n            <\/button>\n        <\/div>\n    <\/div>\n\n\n                \n            <\/section>\n<\/div>\n\t\t\n\t        <\/section>\n","protected":false},"excerpt":{"rendered":"<p>While others focus on a conventional and well trodden ADC development pathway, Allan Jordan (VP, Oncology Drug Discovery) and Josh Greally (ADC Lead) discuss new approaches. This includes a focus on payload optimisation to enhance a drug\u2019s efficacy and selectivity, thereby maximizing its therapeutic benefit. Better performing end products lead to better patient outcomes.<\/p>\n","protected":false},"featured_media":13280,"template":"","category":[744,686],"resource_tag":[],"class_list":["post-13279","webinar-and-podcast","type-webinar-and-podcast","status-publish","has-post-thumbnail","hentry","category-adcs","category-modalities"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Linker Technologies in ADCs: Efficacy and Stability<\/title>\n<meta name=\"description\" content=\"How linker design influences ADC stability, release, and therapeutic impact, helping make informed decisions in molecular engineering.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Linker Technologies in ADCs: Efficacy and Stability\" \/>\n<meta property=\"og:description\" content=\"How linker design influences ADC stability, release, and therapeutic impact, helping make informed decisions in molecular engineering.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-23T17:11:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/episode3-adc-linker-technology-explained.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"320\" \/>\n\t<meta property=\"og:image:height\" content=\"180\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/webinar-and-podcast\\\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/webinar-and-podcast\\\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\\\/\",\"name\":\"Linker Technologies in ADCs: Efficacy and Stability\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/webinar-and-podcast\\\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/webinar-and-podcast\\\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/episode3-adc-linker-technology-explained.webp\",\"datePublished\":\"2025-04-07T16:53:00+00:00\",\"dateModified\":\"2026-01-23T17:11:03+00:00\",\"description\":\"How linker design influences ADC stability, release, and therapeutic impact, helping make informed decisions in molecular engineering.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/webinar-and-podcast\\\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/webinar-and-podcast\\\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/webinar-and-podcast\\\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/episode3-adc-linker-technology-explained.webp\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/episode3-adc-linker-technology-explained.webp\",\"width\":320,\"height\":180,\"caption\":\"Experts in a recorded session discussing how linker technologies affect ADC efficacy and stability.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/webinar-and-podcast\\\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Linker Technologies in ADCs: How They Impact Efficacy and Stability\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Linker Technologies in ADCs: Efficacy and Stability","description":"How linker design influences ADC stability, release, and therapeutic impact, helping make informed decisions in molecular engineering.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/","og_locale":"fr_CA","og_type":"article","og_title":"Linker Technologies in ADCs: Efficacy and Stability","og_description":"How linker design influences ADC stability, release, and therapeutic impact, helping make informed decisions in molecular engineering.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/","og_site_name":"Sygnature","article_modified_time":"2026-01-23T17:11:03+00:00","og_image":[{"width":320,"height":180,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/episode3-adc-linker-technology-explained.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/","name":"Linker Technologies in ADCs: Efficacy and Stability","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/episode3-adc-linker-technology-explained.webp","datePublished":"2025-04-07T16:53:00+00:00","dateModified":"2026-01-23T17:11:03+00:00","description":"How linker design influences ADC stability, release, and therapeutic impact, helping make informed decisions in molecular engineering.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/episode3-adc-linker-technology-explained.webp","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/episode3-adc-linker-technology-explained.webp","width":320,"height":180,"caption":"Experts in a recorded session discussing how linker technologies affect ADC efficacy and stability."},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/linker-technologies-in-adcs-how-they-impact-efficacy-and-stability\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Linker Technologies in ADCs: How They Impact Efficacy and Stability"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/webinar-and-podcast\/13279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/webinar-and-podcast"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/webinar-and-podcast"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/webinar-and-podcast\/13279\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13280"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13279"},{"taxonomy":"resource_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/resource_tag?post=13279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}